Fri, Dec 19, 2014, 3:59 PM EST - U.S. Markets close in 1 min.


% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • G2BAD1 G2BAD1 Oct 19, 2007 1:05 PM Flag

    my two cents

    If I recall correctly, after last earnings report, the stock had a nice run-up because the investors liked the fact that everything was moving according to plan.

    Given no set backs, I would expect the same response after this earnings report (oct 29th).

    Also, I have a hard time believing that SChering's product that did not do so well in Phase I is all of a sudden so effective and safe in Phase II. Something, doesn't add up...or is that they didn't give us a complete picutre. I remember when Vertex announed their first Prove I results the analysts were arguing whether to include drop outs or exclude them in the SVR calculations. My point is that, we haven't seen these calculations and there is a good chance they selected the best possible caluclation not necessarily the most correct one.
    P.S. Bought some leaps and calls recently!


    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Observe that a priming full dose of SOC is given to the first two Arms for 4 weeks prior to the start of SGP's triple combo of duration 24 or 44 weeks. If PROVE 1 had started with such a priming dose for 4 weeks, the PCR values would be certainly higher than we got without it. If the competing two drugs are compared to two sprinters in a race, their PI jumped the gun. It cheated. It is ironic that the trial is known as SPRINT-1.

119.76+2.02(+1.72%)3:59 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.